Emerging Disease Risks: Implications for G7

Our recent report, Industry Reinfected, highlights that 63% of the largest protein-producing companies are ‘High Risk’ when it comes to factors linked to the emergence of new diseases.

The importance of preventing future pandemics is critical to maintaining a healthy, stable global population and economy. This webinar will stress the importance of the adage prevention is cheaper than cure, and highlight the role that investors, policymakers and companies can play in reducing pandemic risk in the food sector – an industry that has been particularly hard hit by the COVID-19 pandemic.

This event brought together experts from academia and the investment space, along with key international organisations, to discuss the findings of the Industry Reinfected report. Panellists discussed matters relating to improved transparency and disclosure of climate and nature-related risks, which could provide the necessary incentives for companies to improve their practices. Additionally, this webinar offered key insights into the material risks associated with emerging diseases and pandemics.

Introduction by Maria Lettini, Executive Director, FAIRR Initiative

Keynote Speakers:

• David Nabarro, Special Envoy on COVID-19 for the World Health Organization (WHO)

• Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance

Panellists:

• Abigail Herron, Global Head of ESG Strategic Partnerships, Aviva Investors

• Stephanie Haszczyn, Policy Officer, the FAIRR Initiative

• Helena Wright, Policy Director, the FAIRR Initiative

• Professor Moreno Di Marco, Head of the Biodiversity and Global Change Lab, Sapienza University of Rome

Watch Now